Drug Profile
SK 962
Latest Information Update: 21 Jul 2010
Price :
$50
*
At a glance
- Originator Sanwa Kagaku Kenkyusho
- Class Analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Stomatitis
Most Recent Events
- 21 Jul 2010 Discontinued - Clinical development for Stomatitis in Japan (Topical)
- 17 Aug 2005 SK 962 is available for licensing (http://www.skk-net.com)
- 17 May 2001 Investigation in Pain in Japan (Topical)